Food & BeverageBeveragesMilk and Dairy

Human Milk Oligosaccharides - Global Market Outlook (2018-2027)

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $4,150 138 Pages Stratistics Market Research Consulting January, 2020 SMR16110989
Lowest Prices Guaranteed
Price from $4,150
Length 138 Pages
Publisher Stratistics Market Research Consulting
Published Date January, 2020
SKU SMR16110989

Human Milk Oligosaccharides - Global Market Outlook (2018-2027)

According to Stratistics MRC, the Global Human Milk Oligosaccharides Market is accounted for $17.90 million in 2018 and is expected to reach $98.05 million by 2027 growing at a CAGR of 21%. Growing application of HMOs in functional foods and increasing demand in infant formula is likely to boost the growth of the market. However, the high cost of production is hindering the growth of the global human milk oligosaccharides market is likely to hamper the profit boundaries.

Human milk oligosaccharides (HMOs) act as prebiotics in human body and help in maintaining gut health. They promote bacterial growth, especially bifidobacteria genus, in the gut, which helps in improving metabolic activity. The antimicrobial protection and prebiotic functions of the product allow them to be used in various food products including pharmaceutical and medicinal food and infant formulas.

Based on the application, the infant formulas are anticipated to grow at the fastest rate during the forecast period. This is attributable to the health benefits associated with the infant formulas such as maintaining gut microbiota and inhibition of pathogen in infants.

By geography, North America recorded the largest share of the global human milk oligosaccharides market revenues. The presence of several major infant formula and baby food manufacturers and technological advancements in the region can be considered major factors driving the market growth.

Some of the key players in the Human Milk Oligosaccharides Market include ZuChem Inc, Medolac Laboratories, Jennewein Biotechnologie GmbH, Inbiose NV, Glycosyn LLC, Glycom A/S and Elicityl S A.

Products Covered:
• Sialyllactose (6’SL)
• Sialyllactose (3’SL)
• Lacto-N-tetraose (LNT)
• Lacto-N-neotetraose (LNnT)
• Fucosyllactose (3’FL)
• Fucosyllactose (2’FL)

Applications Covered:
• Functional Food & Beverages
• Food Supplements
• Infant Formula
• Health Ingredients for Human and Animal
• Other applications

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Human Milk Oligosaccharides Market, By Product
5.1 Introduction
5.2 Sialyllactose (6’SL)
5.3 Sialyllactose (3’SL)
5.4 Lacto-N-tetraose (LNT)
5.5 Lacto-N-neotetraose (LNnT)
5.6 Fucosyllactose (3’FL)
5.7 Fucosyllactose (2’FL)
6 Global Human Milk Oligosaccharides Market, By Applications
6.1 Introduction
6.2 Functional Food & Beverages
6.3 Food Supplements
6.4 Infant Formula
6.5 Health Ingredients for Human and Animal
6.6 Other Applications
7 Global Human Milk Oligosaccharides Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 ZuChem Inc
9.2 Medolac Laboratories
9.3 Jennewein Biotechnologie GmbH
9.4 Inbiose NV
9.5 Glycosyn LLC
9.6 Glycom A/S
9.7 Elicityl S A
List of Tables
Table 1 Global Human Milk Oligosaccharides Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 3 Global Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 4 Global Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 5 Global Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 6 Global Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 7 Global Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 8 Global Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 9 Global Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 10 Global Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 11 Global Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 12 Global Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 13 Global Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 14 Global Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 15 North America Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 16 North America Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 17 North America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 18 North America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 19 North America Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 20 North America Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 21 North America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 22 North America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 23 North America Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 24 North America Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 25 North America Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 26 North America Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 27 North America Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 28 North America Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 29 Europe Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 30 Europe Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 31 Europe Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 32 Europe Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 33 Europe Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 34 Europe Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 35 Europe Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 36 Europe Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 37 Europe Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 38 Europe Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 39 Europe Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 40 Europe Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 41 Europe Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 42 Europe Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 43 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 44 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 45 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 46 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 47 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 48 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 49 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 50 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 51 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 52 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 53 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 54 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 55 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 56 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 57 South America Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 58 South America Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 59 South America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 60 South America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 61 South America Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 62 South America Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 63 South America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 64 South America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 65 South America Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 66 South America Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 67 South America Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 68 South America Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 69 South America Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 70 South America Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 71 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 72 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 73 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 74 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 75 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 76 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 77 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 78 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 79 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 80 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 81 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 82 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 83 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 84 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)

$4,150
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings